Current Status of Beta Blocker Therapy

Overview

Journal Can Fam Physician

Specialties General Medicine
Public Health

Date 2011 Feb 5

PMID 21293573

Authors

J D GRAY

Affiliations

Soon will be listed here.

Abstract

Beta-adrenergic blocking agents are an increasingly important class of drugs to the family physician. Diseases such as ischemic heart disease, hypertension and hyperthyroidism have responded dramatically to beta-blocking therapy. This article summarizes some of the current knowledge on the beta-receptor, the indications for beta-receptor blocking therapy, and the properties of the five beta-blocking agents currently available to Canadian physicians.

References

Diamond S, Medina J . Double blind study of propranolol for migraine prophylaxis. Headache. 1976; 16(1):24-7. DOI: 10.1111/j.1526-4610.1976.hed1601024.x. View

McDevitt D . Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use. Drugs. 1979; 17(4):267-88. DOI: 10.2165/00003495-197917040-00002. View

Greenblatt D, Koch-Weser J . Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program. Drugs. 1974; 7(1):118-29. DOI: 10.2165/00003495-197407010-00008. View

Mackin J, CANARY J, Pittman C . Thyroid storm and its management. N Engl J Med. 1974; 291(26):1396-8. DOI: 10.1056/NEJM197412262912607. View

Simpson F . Beta-adrenergic receptor blocking drugs in hypertension. Drugs. 1974; 7(1):85-105. DOI: 10.2165/00003495-197407010-00006. View

Warren S, BREWER D, ORGAIN E . Long-term propranolol therapy for angina pectoris. Am J Cardiol. 1976; 37(3):420-6. DOI: 10.1016/0002-9149(76)90293-9. View

Miller R, Olson H, Amsterdam E, Mason D . Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975; 293(9):416-8. DOI: 10.1056/NEJM197508282930902. View

WINKLER G, YOUNG R . Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties. N Engl J Med. 1974; 290(18):984-8. DOI: 10.1056/NEJM197405022901802. View

Murray T . Long-term therapy of essential tremor with propranolol. Can Med Assoc J. 1976; 115(9):892-4. PMC: 1879108. View

10.

Lertora J, Mark A, Johannsen J, Wilson W, Abboud F . Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon. J Clin Invest. 1975; 56(3):719-24. PMC: 301921. DOI: 10.1172/JCI108143. View

11.

Foster G, Evans D, Hardcastle J . Heart-rates of surgeons during operations and other clinical activities and their modification by oxprenolol. Lancet. 1978; 1(8078):1323-5. DOI: 10.1016/s0140-6736(78)92401-7. View

12.

Oh V, Kaye C, Warrington S, Taylor E, Wadsworth J . Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise. Br J Clin Pharmacol. 1978; 5(2):107-20. PMC: 1429244. DOI: 10.1111/j.1365-2125.1978.tb01609.x. View

13.

Thadani U, Davidson C, Singleton W, Taylor S . Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med. 1979; 300(14):750-5. DOI: 10.1056/NEJM197904053001402. View

14.

Taggart P, Carruthers M . Suppression by oxprenolol of adrenergic response to stress. Lancet. 1972; 2(7771):256-8. DOI: 10.1016/s0140-6736(72)91689-3. View

15.

Harrison D . Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease. Drugs. 1974; 7(1):1-7. DOI: 10.2165/00003495-197407010-00001. View

16.

Deacon S, Karunanayake A, Barnett D . Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics. Br Med J. 1977; 2(6097):1255-7. PMC: 1632423. DOI: 10.1136/bmj.2.6097.1255. View

17.

Andersen M, Bechsgaard P, Frederiksen J, Hansen D, Jurgensen H, Nielsen B . Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results. Lancet. 1979; 2(8148):865-8. DOI: 10.1016/s0140-6736(79)92684-9. View

18.

Warren S, Warren S . Propranolol and sexual impotence. Ann Intern Med. 1977; 86(1):112. DOI: 10.7326/0003-4819-86-1-112_1. View

19.

MacLeod S, Hamet P, Kaplan H, Larochelle P, Nadeau J, OGILVIE R . Antihypertensive efficacy of propranolol given twice daily. Can Med Assoc J. 1979; 121(6):737-40. PMC: 1704265. View

20.

Hubner P, Ziady G, Lane G, Pridie R, Scales J . Controlled clinical trial of beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy (HOCM). Br Heart J. 1972; 34(9):963. View